Adam Ian Kaplin MD PhD
Neuropsychiatry
Principle Psychiatric Consultant to JHM MS Center, Depts of Psychiatry & Neurology, Assistant Professor of Neurology, Johns Hopkins University School of Medicine
Join to View Full Profile
600 N. Wolfe StreetOsler 320Baltimore, MD 21287
Phone+1 410-929-5544
Fax+1 410-213-3167
Dr. Kaplin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Adam Kaplin, MD, is a psychiatrist based in Baltimore, MD, with a subspecialty in neuropsychiatry. He completed his medical education at Johns Hopkins University School of Medicine, including an internship in internal medicine and a residency in psychiatry. Dr. Kaplin is experienced in psychotherapy and has made notable contributions to research, having authored several publications in esteemed journals, with topics ranging from depression treatment to post-acute sequelae of SARS-CoV-2. His work on SARS-CoV-2 has been particularly influential, as evidenced by its citation frequency. In 2013, he was recognized with the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.
Education & Training
Johns Hopkins UniversityResidency, Psychiatry, 1997 - 2000- Johns Hopkins UniversityInternship, Internal Medicine, 1996 - 1997
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
MD State Medical License 1998 - 2026
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 4 citationsNational Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.Mark J Niciu, Robert C Meisner, Brent R Carr, Ali A Farooqui, David Feifel
Journal of Affective Disorders. 2024-02-01 - A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Do...Jenna Brager, Chris Chapman, Leonard Dunn, Adam Kaplin
Drug Research. 2023-02-01 - 106 citationsAddressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.Anne M. Parker, Emily P. Brigham, Bronwen Connolly, Joanne McPeake, Anna V. Agranovich
The Lancet. Respiratory Medicine. 2021-11-01
Press Mentions
What Top MS Researchers Want You to Know About MS Care and Treatment Right NowMay 25th, 2022- The Never-Ending Battle: New Study Shows Long Covid Can Last at Least 15 MonthsMay 24th, 2022
- Ketamine Therapy Will Go Mainstream in 2022—for Better or WorseDecember 31st, 2021
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/adam-kaplin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
